JP2018517667A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018517667A5 JP2018517667A5 JP2017552909A JP2017552909A JP2018517667A5 JP 2018517667 A5 JP2018517667 A5 JP 2018517667A5 JP 2017552909 A JP2017552909 A JP 2017552909A JP 2017552909 A JP2017552909 A JP 2017552909A JP 2018517667 A5 JP2018517667 A5 JP 2018517667A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- composition
- antibody
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562144247P | 2015-04-07 | 2015-04-07 | |
| US62/144,247 | 2015-04-07 | ||
| PCT/US2016/026436 WO2016164579A1 (en) | 2015-04-07 | 2016-04-07 | Anti-flt-1 antibodies in treating bronchopulmonary dysplasia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020191516A Division JP2021014473A (ja) | 2015-04-07 | 2020-11-18 | 気管支肺異形成症を治療する抗ｆｌｔ−１抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018517667A JP2018517667A (ja) | 2018-07-05 |
| JP2018517667A5 true JP2018517667A5 (https=) | 2019-05-16 |
| JP6797825B2 JP6797825B2 (ja) | 2020-12-09 |
Family
ID=55795198
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017552909A Active JP6797825B2 (ja) | 2015-04-07 | 2016-04-07 | 気管支肺異形成症を治療する抗ｆｌｔ−１抗体 |
| JP2020191516A Pending JP2021014473A (ja) | 2015-04-07 | 2020-11-18 | 気管支肺異形成症を治療する抗ｆｌｔ−１抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020191516A Pending JP2021014473A (ja) | 2015-04-07 | 2020-11-18 | 気管支肺異形成症を治療する抗ｆｌｔ−１抗体 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10711065B2 (https=) |
| EP (2) | EP4063390A1 (https=) |
| JP (2) | JP6797825B2 (https=) |
| CN (1) | CN107683143A (https=) |
| AU (3) | AU2016246738B2 (https=) |
| CA (1) | CA2981961A1 (https=) |
| HK (1) | HK1249913A1 (https=) |
| MA (1) | MA41900A (https=) |
| MX (1) | MX2017012831A (https=) |
| WO (1) | WO2016164579A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019182683A1 (en) * | 2018-03-22 | 2019-09-26 | The Children's Medical Center Corporation | Methods and compositions relating to lung repair |
| US20210261672A1 (en) * | 2018-06-22 | 2021-08-26 | Shire Human Genetic Therapies, Inc. | Anti-flt-1 antibodies in treating bronchopulmonary dysplasia |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7435419B2 (en) * | 2002-07-19 | 2008-10-14 | Beth Israel Deaconess Medical Center | Methods of diagnosing and treating pre-eclampsia or eclampsia |
| US7335362B2 (en) | 2002-07-19 | 2008-02-26 | Beth Israel Deaconess Medical Center | Methods of treating pre-eclampsia or eclampsia |
| ES2534926T3 (es) * | 2002-07-19 | 2015-04-30 | Beth Israel Deaconess Medical Center | Métodos para tratar la preeclampsia |
| US7972596B2 (en) | 2004-11-18 | 2011-07-05 | Imclone Llc | Antibodies against vascular endothelial growth factor receptor-1 |
| US20060153835A1 (en) * | 2005-01-12 | 2006-07-13 | Smith Henry J | Treatment of pre-eclampsia in pregnant women using targeted apheresis |
| US8349325B2 (en) * | 2008-12-23 | 2013-01-08 | Abbott Laboratories | Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making |
| CA2826563C (en) * | 2011-02-07 | 2020-10-20 | Paul Kussie | Methods and systems for treating eclampsia and pre-eclampsia |
| KR102259255B1 (ko) * | 2013-01-28 | 2021-05-31 | 샤이어 휴먼 지네틱 테라피즈 인크. | 뒤시엔느 근위축증의 치료에서의 항-Flt-1 항체 |
| TW201517916A (zh) | 2013-03-15 | 2015-05-16 | Lilly Co Eli | Ｖｅｇｆｒ１抗體之治療用途 |
-
2016
- 2016-04-07 CN CN201680032821.0A patent/CN107683143A/zh active Pending
- 2016-04-07 MA MA041900A patent/MA41900A/fr unknown
- 2016-04-07 US US15/565,009 patent/US10711065B2/en active Active
- 2016-04-07 WO PCT/US2016/026436 patent/WO2016164579A1/en not_active Ceased
- 2016-04-07 MX MX2017012831A patent/MX2017012831A/es unknown
- 2016-04-07 AU AU2016246738A patent/AU2016246738B2/en active Active
- 2016-04-07 JP JP2017552909A patent/JP6797825B2/ja active Active
- 2016-04-07 HK HK18109380.9A patent/HK1249913A1/zh unknown
- 2016-04-07 EP EP22156748.0A patent/EP4063390A1/en active Pending
- 2016-04-07 EP EP16717527.2A patent/EP3280735B1/en active Active
- 2016-04-07 CA CA2981961A patent/CA2981961A1/en active Pending
-
2020
- 2020-06-05 US US16/893,999 patent/US20210130475A1/en not_active Abandoned
- 2020-11-18 JP JP2020191516A patent/JP2021014473A/ja active Pending
-
2022
- 2022-03-15 AU AU2022201781A patent/AU2022201781B2/en active Active
-
2024
- 2024-10-01 AU AU2024227035A patent/AU2024227035A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024150751A5 (https=) | ||
| JP2009541492A5 (https=) | ||
| JP2014158469A5 (https=) | ||
| JP2019513726A5 (https=) | ||
| JPWO2018191479A5 (https=) | ||
| JP2019534710A5 (https=) | ||
| KR20240006585A (ko) | Dll3 및 pd-1을 표적으로 하는 병용 요법을 위한 투여 요법 | |
| JP2017507945A5 (https=) | ||
| KR20220143716A (ko) | 조작된 항-il-2 항체 | |
| JP2013508292A5 (https=) | ||
| JP2018512402A5 (https=) | ||
| CN112351794A (zh) | 用于尿路上皮癌的免疫治疗方法 | |
| JP2020504135A5 (https=) | ||
| JP2023504531A (ja) | 腫瘍治療のための二重特異性融合タンパク質と抗Ｈｅｒ２抗体の組合せ | |
| US20240082394A1 (en) | Combination therapy for the treatment of cancer | |
| JP2018515442A5 (https=) | ||
| JP2018518153A5 (https=) | ||
| JP2018517667A5 (https=) | ||
| JPWO2019246356A5 (https=) | ||
| JP2025172885A (ja) | 腫瘍治療のための二重特異性融合タンパク質 | |
| WO2022057910A1 (en) | Combination therapies targeting c5ar and pd-1/pd-l1 pathways | |
| JP2021535896A5 (https=) | ||
| JPWO2021092380A5 (https=) | ||
| JP2021011484A (ja) | 癌の治療のための抗ｖｅｇｆｒ−２抗体と抗ｐｄ−ｌ１抗体との組み合わせ | |
| US20240287169A1 (en) | Methods of use of anti-il-2 antibodies |